These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 7821886

  • 1. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H, Höxter G.
    Fortschr Med; 1994 Nov 20; 112(32):467-70. PubMed ID: 7821886
    [Abstract] [Full Text] [Related]

  • 2. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
    Hermanns N, Burkert A, Haak T.
    Exp Clin Endocrinol Diabetes; 2004 Jun 20; 112(6):310-4. PubMed ID: 15216448
    [Abstract] [Full Text] [Related]

  • 3. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C, Haupt E, Walter T, Werner J.
    Diabetes Nutr Metab; 2002 Jun 20; 15(3):143-51. PubMed ID: 12173728
    [Abstract] [Full Text] [Related]

  • 4. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH, Wudy A, Eberlein G, Quast C.
    Diabetes Nutr Metab; 1999 Jun 20; 12(3):195-201. PubMed ID: 10554902
    [Abstract] [Full Text] [Related]

  • 5. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C, Hofmann U, Paulwitz O.
    Diabetes Nutr Metab; 2004 Jun 20; 17(3):137-42. PubMed ID: 15334790
    [Abstract] [Full Text] [Related]

  • 6. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.
    Juntti-Berggren L, Pigon J, Hellström P, Holst JJ, Efendic S.
    Diabetes Nutr Metab; 2000 Feb 20; 13(1):7-12. PubMed ID: 10824717
    [Abstract] [Full Text] [Related]

  • 7. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M, Mujica V, Muñoz S, Durruty P, Larenas G, López MI, Kuzmanic A, Pérez J, Flaskamp R, Cumsille F.
    Rev Med Chil; 1997 Aug 20; 125(8):856-62. PubMed ID: 9580485
    [Abstract] [Full Text] [Related]

  • 8. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
    Domke A, Willms B.
    Med Klin (Munich); 1994 Apr 15; 89(4):187-92. PubMed ID: 8015532
    [Abstract] [Full Text] [Related]

  • 9. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
    Soonthornpun S, Rattarasarn C, Thamprasit A, Leetanaporn K.
    J Med Assoc Thai; 1998 Mar 15; 81(3):195-200. PubMed ID: 9623011
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P, Sitagliptin Study 019 Group.
    Clin Ther; 2006 Oct 15; 28(10):1556-68. PubMed ID: 17157112
    [Abstract] [Full Text] [Related]

  • 11. [Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure].
    Heuer LJ, Kaufmann HH.
    Dtsch Z Verdau Stoffwechselkr; 1985 Oct 15; 45(2):52-8. PubMed ID: 3924553
    [Abstract] [Full Text] [Related]

  • 12. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov 15; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 13. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.
    Clin Ther; 2008 May 15; 30(5):858-67. PubMed ID: 18555933
    [Abstract] [Full Text] [Related]

  • 14. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP.
    Diabetes Obes Metab; 2007 Mar 15; 9(2):186-93. PubMed ID: 17300594
    [Abstract] [Full Text] [Related]

  • 15. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S, Turco S, Guarino G, Oliviero B, Rustici A, Torella R.
    Ann Ital Med Int; 1999 Mar 15; 14(1):7-14. PubMed ID: 10528419
    [Abstract] [Full Text] [Related]

  • 16. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy.
    Aubell R, Boehme K, Berchtold P.
    Arzneimittelforschung; 1983 Mar 15; 33(9):1314-8. PubMed ID: 6357206
    [Abstract] [Full Text] [Related]

  • 17. The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose.
    Lecavalier L, Hamet P, Chiasson JL.
    Diabete Metab; 1986 Jun 15; 12(3):156-61. PubMed ID: 3525270
    [Abstract] [Full Text] [Related]

  • 18. [Acarbose, an unduly neglected antidiabetic drug].
    Iványi J, Gyimesi A.
    Orv Hetil; 1996 Dec 08; 137(49):2737-41. PubMed ID: 9679608
    [Abstract] [Full Text] [Related]

  • 19. Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus.
    Dimitriadis G, Karaiskos C, Raptis S.
    Horm Metab Res; 1986 Apr 08; 18(4):253-5. PubMed ID: 3519413
    [Abstract] [Full Text] [Related]

  • 20. A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress.
    Siegelaar SE, Kulik W, van Lenthe H, Mukherjee R, Hoekstra JB, Devries JH.
    Diabetes Obes Metab; 2009 Jul 08; 11(7):709-14. PubMed ID: 19320663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.